Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Align Supplement Industry Regulation With DSHEA, Groups Tell FDA In 'Responsible Innovation' Comments

Jul 19 2019

• By Malcolm Spicer

regulatory compliance concept on the gearwheels, 3D rendering

Related Content

Supplement Claim Guidance Stresses Human Studies, But Leaves Questions

Jan 12 2009

'Innovation' Meeting Shows FDA-Industry Gap On NDI Guidance Details Remains

May 20 2019

Degree Of Difficulty Could Climb For Industry's NDI Investments To Continue

May 20 2019

FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements

Apr 17 2019

NDI Notifications Take Center Stage In FDA's Evaluation Of DSHEA

Apr 10 2019

Autism 'Cure' Products Spur Comment Wave On FDA's VMS Industry Oversight

Jul 19 2019

Additional Topics

United States Dietary Supplements FDA Regulation Advertising, Marketing & Sales Compliance Enforcement Ingredients Legislation Manufacturing Policy Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window